Rally Foundation 20/20: Alumni Visionary Grant
One-time, competitive grant honoring 20 years of Rally funding—reinvesting in past Rally-supported PIs to advance next-phase, potentially transformative pediatric/AYA cancer research.
Eligibility Criteria:
-
Applicant must have previously received Rally funding (as PI) via Rally or its Collaborative Pediatric Cancer Research Awards; if currently funded by Rally, the award period must end by June 30, 2026.
-
Global eligibility; host may be a hospital, university, or private lab.
-
Must address at least one Priority Area (e.g., innovative approaches, basic discovery, understudied cancers, QoL/survivorship/palliative care, targeted/integrative research, data utilization). Proposals not directly relevant to pediatric cancer or infrastructure-only requests are not reviewed.
Funding Details:
-
Up to USD 100,000 per year for 1–2 years (paid semiannually); one-year awards may request a renewal (LOI bypass) in the next cycle.
-
Rally aims to fund up to 20 grants; strong but unfunded applications may be considered for Fellow or Independent Investigator mechanisms (at USD 50,000).
-
No indirect costs; human embryonic stem cell research not funded; funds must be used for the approved project scope.
Deadline:
-
LOI: opens August 4, 2025; closes September 12, 2025 (3:30 PM EDT).
-
Invited Full Application: opens November 6, 2025; due January 6, 2026 (3:30 PM EST).
-
Earliest notice: April 1, 2026; start date: July 1, 2026.
Where to Go for Further Information:
-
Submit via ProposalCentral (search “20/20: Alumni Visionary Grant”).
- Program information.
-
Grant manager: Leigh Anna Lang, [email protected].
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023